• Journals Master List
  • DOAJ
  • 数据库logo
  • EuroPub
TANG Dai-rong, XIE Xian-da, LIAO Xiang-ping. Clinical significance of urine hepcidin in lupus nephritis[J]. Journal of Clinical Nephrology, 2017, 17(8): 490-494. DOI: 10.3969/j.issn.1671-2390.2017.08.009
Citation: TANG Dai-rong, XIE Xian-da, LIAO Xiang-ping. Clinical significance of urine hepcidin in lupus nephritis[J]. Journal of Clinical Nephrology, 2017, 17(8): 490-494. DOI: 10.3969/j.issn.1671-2390.2017.08.009

Clinical significance of urine hepcidin in lupus nephritis

More Information
  • Received Date: April 03, 2017
  • Rev Recd Date: July 13, 2017
  • Available Online: May 11, 2023
  • Published Date: August 27, 2017
  • Objective To test the level of urine hepcidin (Hepc) in systemic lupus erythematosus (SLE) patients with renal damage, study the relationship between the level of urine Hepc and lupus nephritis (LN), and to further investigate the relationship between urine Hepc and active LN. Methods This experiment included 38 healthy subjects (29 females and 9 males) and 54 cases of SLE (46 females and 8 males). According to the renal damage, all SLE patients were divided into SLE non-LN group (12 cases) and SEL LN group (42 cases). The enzyme-linked immunosorbent assay (ELISA) was used to measure the level of urine Hepc. Forty-two cases of LN were divided into inactive LN group (10 cases) and active LN group (32 cases) according to Renal-Systemic Lupus Erythematosus Disease Activity Index (R-SLEDAI). The level of urine Hepc was compared between inactive LN group and active LN group, and the relationship between the R-SLEDAI and urinary Hepc was analyzed. At the same time, the activity of LN was predicted according to the Hepc values, and the sensitivity and specificity were analyzed by receiver operating characteristic curve (ROC curve). Results The level of urine Hepc in SLE LN group was significantly higher than SLE non-LN group and healthy control group (both P<0.01). The level of urine Hepc in active LN group was significantly higher than that in inactive LN group (P<0.001). The urine Hepc in LN patients was positively correlated with the R-SLEDAI score (r=0.313, P=0.043), and there was no correlation between SLEDAI and renal RSLEDAI score (P>0.05). Cut-off in urine Hepc was 7.483 ng/ml (90.62% for sensitivity, and 80% for specificity). The area under the ROC curve was 0.897, greater than that of complement C3, C4, serum creatinine and serum anti ds-DNA antibody, but less than that of 24-h urinary protein quantity. Conclusions The expression level of urine Hepc in the SLE patients with renal involvement may be a new indicator of LN activity.
  • [1]
    Brugos B, Zeher M. Biomarkers in lupus nephritis[J]. Orv Hetil, 2010, 151(29):1171-1176.
    [2]
    Balow JE. Clinical presentation and monitoring of lupus nephritis[J]. Lupus, 2005, 14(1):25-30.
    [3]
    Ashby DR, Gale DP, Busbridge M, et al. Plasma Hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease[J]. Kidney Int, 2009, 75(9):976-981.
    [4]
    Bennett M, Bruner HI. Biomarkers and updates on pediatrics lupus nephritis[J]. Rheum Dis Clin North Am, 2013, 39(4):833-853.
    [5]
    Swinkels DW, Girelli D, Laarakkers C, et al. Advances in quantitative Hepcidin measurements by time-of-flight mass spectrometry[J]. PLoS One, 2008, 3(7):e2706.
    [6]
    Jelic M, Cvetkovic T, Djordjevic V, et al. Hepcidin and iron metabolism disorders in patients with chronic kidney disease[J]. Vojnosanit Pregl, 2013, 70(4):368-373.
    [7]
    Fufaa GD, Weil EJ, Nelson RG, et al. Urinary monocyte chemoattractant protein-1 and Hepcidin and early diabetia nephropathy lesion in type 1 diabetes mellitus[J]. Nephrol Dial Transplant, 2015, 30(4):599-606.
    [8]
    袁红, 曾雪曦. 狼疮性肾炎的研究进展[J]. 国际检验医学杂志, 2016, 37(4):523-526.
    [9]
    Mohammed MF, Belal D, Bakry S, et al. A study of Hepcidin and monocyte chemoattractant protein-1 in Egyptian females with systemic lupus erythematosus[J]. J Clin Lab Anal, 2014, 28(4):306-309.
    [10]
    Zhang X, Nagaraja HN, Nadasdy T, et al. A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies[J]. Kidney Int, 2012, 81(4):401-406.
    [11]
    Bennett M, Brunner HI.Biomarkers and updates on pediatrics lupus nephritis[J]. Rheum Dis Clin N Am, 2013, 39(4):833-853.
    [12]
    Zhang X, Jin M, Wu H, et al. Biomarkers of lupus nephritis determined by serial urine proteomics[J]. Kidney Int, 2008, 74(6):799-807.
    [13]
    Troutt JS, Butterfield AM, Konrad RJ. Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates[J]. J Clin Lab Anal, 2013, 27(6):504-510.
    [14]
    Lukaszyk E, Lukaszyk M, Koc-Zorawska E, et al. Iron status and inflammation in early stages of chronic kidney disease[J]. Kidney Blood Press Res, 2015, 40(4):366-373.
    [15]
    Parodis I, Zickert A, Sundelin B, et al. Evaluation of B lymphocyte stimulator and a proliferation inducing ligand ascandidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy[J]. Lupus Sci Med, 2015, 2(1):e000061.
    [16]
    常春康, 张曦, 肖超, 等. 铁调素的表达与调节机制研究进展[J]. 中国实验血液学杂志, 2012, 20(4):1030-1033.
    [17]
    Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing it internalization[J]. Science, 2004, 306(5704):2090-2093.
    [18]
    Indrakanti DL, Alvarado A, Zhang X, et al. The interleukin-6-Hepcidin-hemoglobin circuit in systemic lupus erythematosus flares[J]. Lupus, 2016:0, 1-4.
  • Related Articles

    [1]Zhai Hong-fu, Ni Li-hua, Wu Xiao-yan. Association of urinary heme oxygenase with renal damage and activity in patients with systemic lupus erythematosus[J]. Journal of Clinical Nephrology, 2024, 24(8): 629-635. DOI: 10.3969/j.issn.1671-2390.2024.08.003
    [2]Lu Xiao-juan, Zhang Yu. Relationship between peripheral blood lymphocyte subset characteristics and prognoses in children with lupus nephritis[J]. Journal of Clinical Nephrology, 2024, 24(6): 494-501. DOI: 10.3969/j.issn.1671-2390.2024.06.008
    [3]Tian Gui-qing, Li Zhen-qiong. Research advances in targeted therapy of lupus nephritis[J]. Journal of Clinical Nephrology, 2024, 24(4): 319-323. DOI: 10.3969/j.issn.1671-2390.2024.04.009
    [4]Liu Chao, Yu Xiao-yang, Wang Zhi-gang, Zhao Can. Exploratory study of serum IL-36 subfamily as biomarkers of disease progression in lupus nephritis[J]. Journal of Clinical Nephrology, 2023, 23(10): 798-804. DOI: 10.3969/j.issn.1671-2390.2023.10.002
    [5]He Shi-ting, Xie Wei-ji, Zhang Yi-min. Controversies of systematic lupus erythmatousus and lupus nephritis[J]. Journal of Clinical Nephrology, 2023, 23(5): 421-427. DOI: 10.3969/j.issn.1671-2390.2023.05.012
    [6]Zhao Qian-qian, Wang Si-yang, Zhao Kang-jie, Zhao Zhan-zheng, Shang Jin. Seronegative systemic lupus erythematosus with membranous proliferative glomerulonephritis as an initial manifestation: one case report[J]. Journal of Clinical Nephrology, 2021, 21(11): 967-969. DOI: 10.3969/j.issn.1671-2390.2021.11.015
    [7]Li Bo-jiang, Xiao You-wen, Dong Jian-hua, He Ling, Pan Hong-xia, Fang Mei-rong. Relationship of anemia with disease activity and renal damage in patients with systemic lupus erythematosus[J]. Journal of Clinical Nephrology, 2021, 21(2): 124-129. DOI: 10.3969/j.issn.1671-2390.m20-111
    [8]LI Chun-hong, TIAN Jie. The impacts of gender differences on systemic lupus erythematosus and lupus nephritis[J]. Journal of Clinical Nephrology, 2019, 19(8): 628-632. DOI: 10.3969/j.issn.1671-2390.2019.08.016
    [9]YANG Shi-xia. Clinical effects of glucocorticoid combined with Buyang Huanwu Decoction for mild and moderate systemic lupus erythematosus[J]. Journal of Clinical Nephrology, 2018, 18(6): 344-347. DOI: 10.3969/j.issn.1671-2390.2018.06.005
    [10]ZHANG Li, DOU Yan-na, MA Shuang, XIAO Jing, CHENG Gen-yang, LIU Dong, ZHAO Zhan-zheng. A case report and literature review of systemic lupus erythematosus with diffuse alveolar hemorrhage[J]. Journal of Clinical Nephrology, 2017, 17(3): 160-163. DOI: 10.3969/j.issn.1671-2390.2017.03.006

Catalog

    Article views (20) PDF downloads (321) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return